 Aim 1. Conduct a clinic-randomized trial of the impact of an evidence-based point-of-care CDS system on i overall CVD risk scores, and ii control of individual CVD risks blood pressure; HbA1c, lipid levels; aspirin use; smoking; body mass index, among high CVD risk CHC adult patients. H1: High CVD risk patients in Arm 1 CHCs will have significantly lower overall CVD risk scores over a 12-month post-index visit period, compared to those in Arm 2 CHCs. H2: High CVD risk patients in Arm 1 CHCs who have poor control of specific CVD risk factors at an index visit will have significantly better control of those factors over a 12 month post-index visit period, compared to those in Arm 2 CHCs. H3: Disparities in specific CVD risk factor control between CHC patients versus national CVD risk factor control rates will be significantly reduced by 18 months post-implementation in each Arm secondary analysis. 